Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Conbercept by Chengdu Kanghong Pharmaceuticals Group for Retinoblastoma: Likelihood of Approval
Conbercept is under clinical development by Chengdu Kanghong Pharmaceuticals Group and currently in Phase II for Retinoblastoma. According to GlobalData,...